Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Billings

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
Nutrition and Cancer|January 1, 1993
Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBAA R Kennedy, P C Billings, P A Maki, et al.
Nutrition and Cancer|February 18, 2003
Effects of Bowman-Birk inhibitor on rat colon carcinogenesisAnn R Kennedy, Paul C Billings, X Steven Wan, et al.
Cancer Biochemistry Biophysics|January 1, 1995
A post-labeling technique for the iodination of DNA damage recognition proteinsP C Billings, J E Cryer, L Y Moy, et al.
Molecular Carcinogenesis|January 1, 1990
Effects of protease inhibitors on c-myc expression in normal and transformed C3H 10T1/2 cell linesJ D Chang, J H Li, P C Billings, et al.
Cancer Research|October 15, 1991
Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitorP C Billings, J M Habres, D C Liao, et al.
The Journal of Biological Chemistry|January 19, 2001
Authentic matrix vesicles contain active metalloproteases (MMP). a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-betaM D'Angelo, P C Billings, M Pacifici, et al.
Carcinogenesis|June 1, 1987
Inhibition of radiation-induced transformation of C3H/10T1/2 cells by chymotrypsin inhibitor 1 from potatoesP C Billings, W St Clair, C A Ryan, et al.
Plos One|September 20, 2019
Identification and characterization of a novel heparan sulfate-binding domain in Activin A longest variants and implications for functionEvan Yang, Christina Mundy, Eric F Rappaport, et al.
Nutrition and Cancer|January 1, 1993
Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrateA R Kennedy, B F Szuhaj, P M Newberne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatinJ E Cryer, S W Johnson, B N Engelsberg, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
Nutrition and Cancer|January 1, 1993
Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBAA R Kennedy, P C Billings, P A Maki, et al.
Nutrition and Cancer|February 18, 2003
Effects of Bowman-Birk inhibitor on rat colon carcinogenesisAnn R Kennedy, Paul C Billings, X Steven Wan, et al.
Cancer Biochemistry Biophysics|January 1, 1995
A post-labeling technique for the iodination of DNA damage recognition proteinsP C Billings, J E Cryer, L Y Moy, et al.
Molecular Carcinogenesis|January 1, 1990
Effects of protease inhibitors on c-myc expression in normal and transformed C3H 10T1/2 cell linesJ D Chang, J H Li, P C Billings, et al.
Cancer Research|October 15, 1991
Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitorP C Billings, J M Habres, D C Liao, et al.
The Journal of Biological Chemistry|January 19, 2001
Authentic matrix vesicles contain active metalloproteases (MMP). a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-betaM D'Angelo, P C Billings, M Pacifici, et al.
Carcinogenesis|June 1, 1987
Inhibition of radiation-induced transformation of C3H/10T1/2 cells by chymotrypsin inhibitor 1 from potatoesP C Billings, W St Clair, C A Ryan, et al.
Plos One|September 20, 2019
Identification and characterization of a novel heparan sulfate-binding domain in Activin A longest variants and implications for functionEvan Yang, Christina Mundy, Eric F Rappaport, et al.
Nutrition and Cancer|January 1, 1993
Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrateA R Kennedy, B F Szuhaj, P M Newberne, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatinJ E Cryer, S W Johnson, B N Engelsberg, et al.
Pageof 14